Apoptosis-related prognostic biomarkers and potential targets for acute kidney injury based on machine learning algorithm and in vivo experiments

• Published in: Apoptosis (London) Vol. 29; no. 3-4; pp. 303 - 320
• Main Authors: Guo, Hanyao, Wang, Meixia, Shang, Yanan, Zhang, Bo, Zhang, Sidi, Liu, Xiaoyu, Cao, Pengxiu, Fan, Yumei, Tan, Ke
• Format: Journal Article
• Language: English
• Published: New York Springer US 01.04.2024; Springer; Springer Nature B.V
• Subjects: Acute Kidney Injury - genetics; Algorithms; Animal models; Animals; Apoptosis; Apoptosis - genetics; B cells; Biochemistry; Biological markers; Biomarkers; Biomedical and Life Sciences; Biomedicine; Cancer Research; Cell Biology; Cisplatin; Collagen (type I); Creatinine; Data mining; Diagnosis; Diagnostic systems; Epidermal growth factor; Folic acid; Gene expression; Gene sequencing; Genes; Glomerular Filtration Rate; Humans; Immune system; Infiltration; Kidney diseases; Kidneys; Machine learning; Medical research; Medicine, Experimental; Mice; Network analysis; Oncology; Patients; Prognosis; Regression analysis; RNA; RNA sequencing; Sequence analysis; Virology; Immune cell infiltration; Clinical diagnosis; Apoptosis-related genes; WGCNA; Acute kidney injury
• ISSN: 1360-8185; 1573-675X
• DOI: 10.1007/s10495-023-01896-4

Acute kidney injury (AKI) is a common critical illness in hospitalized patients, characterized by a rapid decline in kidney function over a short period, which can seriously endanger the patient’s life. Currently, there is a lack of precise and universal AKI diagnostic biomarkers in clinical practice. In this study, weighted gene coexpression network analysis (WGCNA), differential expression analysis, univariate and multivariate logistic regression analyses, receiver operating characteristic (ROC) curves, and immune cell infiltration were performed to identify apoptosis-related biomarkers that can be used for AKI diagnosis. Three core apoptosis-related genes (ARGs), CBFB, EGF and COL1A1, were identified as AKI biomarkers. More importantly, an apoptosis-related signature containing three hub ARGs was validated as a diagnostic model. The hub genes exhibited good correlations with glomerular filtration rate (GFR) and serum creatinine (SCr) in the Nephroseq kidney disease database. Additionally, CIBERSORT immune infiltration analysis indicated that these core ARGs may affect immune cell recruitment and infiltration in AKI patients. Subsequently, we investigated the alteration of the expression levels of three core ARGs in AKI samples using single-cell RNA sequencing analysis and analyzed the cell types that mainly expressed these ARGs. More importantly, the expression of core ARGs was validated in folic acid- and cisplatin-induced AKI mouse models. In summary, our study identified three diagnostic biomarkers for AKI, explored the roles of ARGs in AKI progression and provided new ideas for the clinical diagnosis and treatment of AKI.